Lifeline Biotechnologies, Inc. carries a market capitalization of 2.17M, placing it among publicly traded companies globally.
| Market Cap | 2.17M |
| Enterprise Value | N/A |
Lifeline Biotechnologies, Inc.'s stock has gained approximately 25% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.
| Beta (5Y) | N/A |
| 52-Week Price Change | 25% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Average Volume (20 Days) | N/A |
Lifeline Biotechnologies, Inc.'s most recent stock split took place on September 5, 2008 with a 150:1 split ratio.
| Last Split Date | 9/5/2008 |
| Split Ratio | 150:1 |